Bender Jeremy — SEC Form 4 filings
SEC reporting owner CIK 1863107. 25 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-01-09 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 10 filings — 189,357 shares, $2,608,564 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 130.
- Largest priced transaction: sale of 70,051 shares @ $17.88 ($1,252,183) in Day One Biopharmaceuticals, Inc., filed 2024-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER, Director | 18 | — | 12 legs · 189,357 sh · $2,608,564 | 119 |
| Mereo BioPharma Group plc (MREO) | Director | 4 | — | — | 7 |
| Aura Biosciences, Inc. (AURA) | Director | 1 | — | — | 2 |
| Bicara Therapeutics Inc. (BCAX) | Director | 1 | — | — | 1 |
| Fusion Pharmaceuticals Inc. (FUSN) | Director | 1 | — | — | 1 |
Form 4 filings — Bender Jeremy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Bicara Therapeutics Inc. (BCAX) | Grant/award (A): 38,950 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 204,643 · Disposition to issuer (D): 20,204 · Disposition to issuer (D): 300,000 · Disposition to issuer (D): 147,702 · Disposition to issuer (D): 18,197 · Disposition to issuer (D): 300,000 · +11 more | EDGAR |
| 2026-02-27 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 66,000 (derivative) @ $0 · Grant/award (A): 117,533 (derivative) | EDGAR |
| 2026-02-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 4,750 · Option exercise (M): 11,688 · Option exercise (M): 11,687 · Option exercise (M): 14,812 · Sale (S): 15,459 @ $11.60 · Option exercise (M): 4,750 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-30 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 355,000 (derivative) @ $0 · Grant/award (A): 237,000 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 7,225 @ $0 · Gift (G): 7,225 @ $0 | EDGAR |
| 2025-11-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,570 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 15,894 @ $8.91 · Option exercise (M): 3,570 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-07 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 1,463,134 (derivative) @ $0 · Grant/award (A): 1,463,134 (derivative) @ $0 · Disposition to issuer (D): 397,000 (derivative) @ $0 · Grant/award (A): 397,000 (derivative) @ $0 · Disposition to issuer (D): 244,000 (derivative) @ $0 · Grant/award (A): 244,000 (derivative) @ $0 · +4 more | EDGAR |
| 2025-08-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 16,058 @ $6.77 · Option exercise (M): 3,562 (derivative) @ $0 · +3 more | EDGAR |
| 2025-07-14 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Gift (G): 148,312 @ $0 · Gift (G): 148,312 @ $0 · Gift (G): 74,328 @ $0 · Gift (G): 74,328 @ $0 · Gift (G): 199,202 @ $0 · Gift (G): 199,202 @ $0 · +2 more | EDGAR |
| 2025-05-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 13,964 @ $6.26 · Option exercise (M): 3,562 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-21 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 12,048 @ $11.96 · Option exercise (M): 3,562 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-06 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 16,768 (derivative) | EDGAR |
| 2025-01-31 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 286,000 (derivative) @ $0 · Grant/award (A): 187,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Sale (S): 10,554 @ $13.21 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 4,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-08-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Sale (S): 10,681 @ $14.00 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 4,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-05 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Gift (G): 59,075 @ $0 · Gift (G): 59,075 @ $0 · Gift (G): 29,606 @ $0 · Gift (G): 29,606 @ $0 · Gift (G): 80,619 @ $0 · Gift (G): 80,619 @ $0 · +2 more | EDGAR |
| 2024-06-17 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 12,550 @ $3.99 | EDGAR |
| 2024-06-04 | 4 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to issuer (D): 34,000 (derivative) | EDGAR |
| 2024-05-17 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Sale (S): 7,873 @ $16.08 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 4,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-05-03 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Sale (S): 70,051 @ $17.88 · Sale (S): 6 @ $17.94 · Sale (S): 9,154 @ $17.85 | EDGAR |
| 2024-02-20 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Sale (S): 7,615 @ $15.25 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 4,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-09 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 16,361 (derivative) | EDGAR |
| 2024-01-09 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 286,000 (derivative) @ $0 · Grant/award (A): 187,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1863107 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →